Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | ATRA | FIMM | pan-cancer | AAC | -0.36 | 0.01 |